EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.

Last updated 22 svibnja 2024. Database contains 4821 unique substances/entries.
Filter the list

A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produces a finished oil with a viscosity in the order of 17cSt to 23cSt at 40°C (104°F).
309-875-6
101316-70-5
Carc. 1B
A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40°C (104°F).
309-876-1
101316-71-6
Carc. 1B
A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40°C (104°F).
309-877-7
101316-72-7
Carc. 1B
A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100°C (212°F).
309-874-0
101316-69-2
Carc. 1B
CGA 184699
410-690-9
103055-07-8
Skin Sens. 1
202-987-5
101-90-6
Carc. 1B; Muta. 2; Acute Tox. 3; Acute Tox. 4; Skin Irrit. 2; Eye Irrit. 2; Skin Sens. 1
203-577-9
108-39-4
Acute Tox. 3; Skin Corr. 1B
PRODUCT 5899
404-150-1
17092-80-7
Skin Irrit. 2
203-584-7
108-45-2
Muta. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
203-583-1
108-44-1
Acute Tox. 3; STOT RE 2
203-576-3
108-38-3
Flam. Liq. 3; Acute Tox. 4; Skin Irrit. 2
DUPLOSAN-DP-MAGNESIUM
413-360-2
164058-21-3
Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
241-022-2
16949-65-8
Acute Tox. 3
235-023-7
12057-74-8
Water-react. 1; Acute Tox. 2; Acute Tox. 3; Acute Tox. 1
204-497-7
121-75-5
Acute Tox. 4; Skin Sens. 1
203-742-5
110-16-7
Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1
203-571-6
108-31-6
Acute Tox. 4; STOT RE 1; Skin Corr. 1B; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1A
203-703-2
109-77-3
Acute Tox. 3
235-654-8
12427-38-2
Repr. 2; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
215-202-6
1313-13-9
Acute Tox. 4
239-924-6
15825-70-4
Unst. Expl.
239-924-6
15825-70-4
Expl. 1.1
240-539-0
16484-77-8
Acute Tox. 4; Eye Dam. 1
205-275-2
137-05-3
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
204-987-0
130-37-0
Eye Irrit. 2; Skin Irrit. 2
432-140-7
110235-47-7
Carc. 2
205-769-8
150-76-5
Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
203-604-4
108-67-8
Flam. Liq. 3; STOT SE 3
600-533-4
104206-82-8
Repr. 2; STOT RE 2
604-167-6
139968-49-3
Repr. 2; Lact.; STOT RE 2
205-293-0
137-42-8
Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
603-031-3
125116-23-6
Repr. 2; Acute Tox. 4
204-817-5
126-98-7
Flam. Liq. 2; Acute Tox. 3; Skin Sens. 1
233-606-0
10265-92-6
Acute Tox. 2; Acute Tox. 3
202-905-8
100-97-0
Flam. Sol. 2; Skin Sens. 1
240-815-0
16752-77-5
Acute Tox. 2
241-420-6
17392-83-5
Flam. Liq. 3; Eye Irrit. 2; STOT SE 3
DISPERSE RED CLA 282
416-240-8
155522-12-6
Skin Sens. 1
JE 127
421-220-7
144740-59-0
Skin Sens. 1
LUGALVAN ES 9571
420-940-9
15768-07-7
Eye Irrit. 2; Skin Irrit. 2
MEFAT
404-130-2
105560-93-8
Eye Dam. 1; Skin Sens. 1
620-362-9
1918-18-9
Acute Tox. 4
425-190-6
119916-05-1
STOT RE 2
MAT 9460
414-080-3
117291-73-3
Acute Tox. 4
203-299-8
105-45-3
Eye Irrit. 2
203-481-7
107-31-3
Flam. Liq. 1; Acute Tox. 4; Eye Irrit. 2; STOT SE 3
FAT 40'489
413-040-2
149850-30-6
Skin Sens. 1
414-460-9
105726-67-8
Acute Tox. 4
204-317-7
119-36-8
Repr. 2; Acute Tox. 4; Skin Sens. 1B
203-475-4
107-25-5
Flam. Gas 1; Press. Gas

Export search results to: